I got out last week, and my money from my bank made it in, love the technology. So, I'm looking at buying BIGN watching it close first 15 minutes.
Half BIGN and Half INsq
it's going to have to have a hell of a run this afternoon to get to .05
-------------------- Sometimes the poorest man leaves his children the richest inheritance. Posts: 804 | From: Woodbridge, Va | Registered: Aug 2005
| IP: Logged |
posted
TORONTO, Oct. 18, 2005 (PRIMEZONE) -- Biogenerics Limited (Pink Sheets:BIGN): The company is pleased to announce that it has secured an agreement with an institutional investor Royal Petroleum. Royal Petroleum purchases and finances producing oil and gas wells. Biogenerics has financing in place for hydroslotting at 8.5% interest as needed and secured by our current production.
Biogenerics plans to primarily fund the hydroslotting expansion with its current cashflow. This is possible since the costs for slotting are returned in an average of 45 days from production. Having Royal Petroleum behind us eliminates the need for any financings which may cause dilution of equity.
Biogenerics' Paul Smith states that, "This hydroslotter joint venture is offering perhaps the most capital efficient way to create aggressive economic returns without exploration risk. Now that we have the ability to draw down the capital required we can aggressively move forward."
A number of statements contained in this press release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including timely development, and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions and the ability to secure additional sources of financing. The actual results of WW Energy Inc. may achieve could differ materially from any forward-looking statements due to such risks and uncertainties, including but not limited to, the fact that no assurance can be given that any proposed acquisitions will be consummated at all.
CONTACT: Biogenerics Limited Investor Relations Paul Smith 905-714-9422
Posts: 157 | From: IL | Registered: Jul 2005
| IP: Logged |
posted
"...we expect US$43,200,000.00 in profits for 2006..." (Oct 14 PR). --------------------------------------------- If that's true, that's .19 per share profit based on current O/S (224+ million). Not too bad.
Posts: 798 | Registered: Jun 2004
| IP: Logged |
Biogenerics Limited Prepares for Dual Listing in UK and Reiterates Impact of Recently Announced Royal Petroleum Financing Commitment
October 20, 2005 10:30:10 (ET)
TORONTO, Oct 20, 2005 (PRIMEZONE via COMTEX) -- Biogenerics Limited (Pink Sheets:BIGN) is pleased to announce that it is currently finalizing arrangements, and expects to soon commence trading BIGN in Europe via an exchange listing in the United Kingdom. Biogeneric's Paul Smith stated, "Over the past few months, the Company has developed a strong following among European investors, and we are instituting this dual listing to enable folks in the EU to invest in BIGN more efficiently and to hold positions in their home currencies. Having become accustomed to paying the equivalent of $5 to $6 dollars a gallon for gasoline, Europeans are especially attuned to the looming energy crisis facing the U.S., and see excellent value in burgeoning companies like ours that utilize cutting edge technology to economically extend dormant, shut-in U.S. energy resources."
In addition, Biogeneric's management reiterated the impact of this Tuesday's Press Release whereby Royal Petroleum has agreed to provide traditional debt-based financing for Biogeneric's upcoming schedule of oil and gas re-completion projects. Terms announced for the financing include an 8.5% credit facility to support wellhead completion expenses for hydroslotting, secured by current cash flow of the Company's existing portfolio of producing oil & gas properties. Biogeneric's Paul Smith stated, "This is tremendous news for the company and for our shareholders. The Company already has well over $1 million in reserve cash on its balance sheet to support our current hydroslotting schedule, which we knew was going to allow us to leverage our growth without raising additional equity financing and diluting our capital structure. The credit facility we have now put in place with Royal Petroleum is going to allow the Company to step to the plate with an even more aggressive re-completion schedule on a non-dilutive basis, and provides the catalyst for us to hyper-grow the Company's resource production and income streams. Over the past 6 months, we have been aggressively locating and securing additional dormant energy properties that fit the hydroslotter criteria for re-development. Now that the company has secured an almost inexhaustible 'war chest' to bring the remainder of our existing, as well as target properties into production, our growth will now only be limited by how quickly we are able secure new properties, move hydroslotter equipment to the sites, and commence re-completion operations."
Biogenerics estimates their breakeven on a $200,000 hydro-slotted re-completion to be in the 30 to 60 day range based on several projects like the recently announced Grimes, CA gas well that flowed 14,400 mcf (1 mcf = 1,000 cubic feet) in its first month. At recent gas prices of $10 per mcf, this well produces approximately $140,000 in cash flow per month, of which 40% or nearly $60,000 per month (after payback of hydro-slotting cash outlay) is realized by Biogenerics after royalty payments and expenses.
Prior to the Royal Petroleum announcement, the company's strategy suggested re-completing, and bringing on line 10 new wells per month in 2006. In 2007 the Company expects to double that rate to hydroslotting 20 wells per month.
Based on $10 per mcf gas, and upon each of the forecasted 120 wells completed in 2006 averaging a production rate of 500 mcf/day, in conjunction with alternate wells coming on stream in 2005, the Company is forecasting a daily cash flow run rate of US $240,000 at year-end 2006. This would put the company on an annualized run rate of $87.6 million.
About Biogenerics Limited:
Biogenerics is a diversified investment venture capital firm focused on exploiting and distributing domestic oil and gas reserves. Biogenerics also has joint venture activities with Tyche Energy, Hydroslotter Coporation and WW Energy Inc.
About Hydroslotter Corporation:
Hydroslotter Corporation's, proprietary technology deemed "hydroslotting" increases oil and gas production and extends commercial productivity of oil and gas by 300% to 600%.
A number of statements contained in this press release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Act of 1995. These forward-looking statements involve a number of risks and uncertainties, including timely development, and market acceptance of products and technologies, competitive market conditions, successful integration of acquisitions and the ability to secure additional sources of financing. The actual results of WW Energy Inc. may achieve could differ materially from any forward-looking statements due to such risks and uncertainties, including but not limited to, the fact that no assurance can be given that any proposed acquisitions will be consummated at all.
posted
"...Based on $10 per mcf gas, and upon each of the forecasted 120 wells completed in 2006 averaging a production rate of 500 mcf/day, in conjunction with alternate wells coming on stream in 2005, the Company is forecasting a daily cash flow run rate of US $240,000 at year-end 2006. This would put the company on an annualized run rate of $87.6 million...." _______________________________ In my estimation, if this becomes reality, this stock should be selling for over $ 1.00 per share at the end of 2006.
Posts: 798 | Registered: Jun 2004
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
